REPLIGEN CORP: IF DEAL TERMINATED UNDER SOME CIRCUMSTANCES, BIOLIFE MAY BE REQUIRED TO PAY REPLIGEN A TERMINATION FEE OF $59 MLN

Reuters · 3d ago

Please log in to view news